Skip to main content
Equibles

Lafayette Investments, Inc.

Position in LCTX — Lineage Cell Therapeutics, Inc.

CIK 1308377 ASHTON, MD
Back to LCTX Full portfolio

Position in LCTX

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$17,030
-$3,510 QoQ
Shares Held
13,000
0.0% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#87
of 130 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in LCTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Lafayette Investments, Inc. holds $34,494 across 2 Biotechnology names. LCTX ranks #2 (49.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RANI
Rani Therapeutics Holdings, Inc.
 22,979 $17,464
2 LCTX
Lineage Cell Therapeutics, Inc.
This page 		13,000 $17,030

All Filings in LCTX

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $17,030 13,000
2026-03-31 $20,540 13,000
2025-12-31 $21,710 13,000
2025-09-30 $21,970 13,000
2025-06-30 $11,830 13,000
2025-03-31 $5,850 13,000
2024-12-31 $6,500 13,000
2024-09-30 $11,830 13,000
2024-06-30 $13,000 13,000
2024-03-31 $19,240 13,000
2023-12-31 $14,170 13,000
2023-09-30 $15,340 13,000
2023-06-30 $18,330 13,000
2023-03-31 $19,500 13,000
2022-12-31 $15,210 13,000
2022-09-30 $14,690 13,000
2022-06-30 $20,540 13,000
2022-03-31 $20,020 13,000
2021-12-31 $31,850 13,000
2021-09-30 $32,760 13,000
2021-06-30 $37,050 13,000
2021-03-31 $30,550 13,000
2020-12-31 $17,600 10,000